Platinum resistant recurrent ovarian cancer Overall Survival
A tool for researcher and health care professionals to prognosticate overall survival outcomes in patients with platinum resistant recurrent ovarian cancer treated with chemotherapy.
Disclaimer & Privacy
The NHMRC clinical Trials Centre strives to keep information stored in the PROC Online tool up to date, but does not guarantee the accuracy, reliability or currency of the information. Any errors in the information that are brought to our attention will be corrected as soon as possible. The CTC reserves the right to change at any time without notice any information stored in the ROC Online tool.
The CTC may provide links to a number of external websites via this website. Monitoring and reviewing content of these third party external websites is not the responsibility of the CTC nor does the CTC endorse, approve or recommend the content, owners or operators of websites and applications available through this website.
The CTC accepts no liability for any loss or damage a person suffers because that person has directly or indirectly relied on any information stored on this server.